Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san francisco blog main
4
×
san francisco top stories
boston blog main
boston top stories
clinical trials
national top stories
new york blog main
new york top stories
biotech ipos
cancer
cancer drugs
deals
hepatitis b
medical device
pfizer
san francisco
startups
the column group
10x genomics
abbvie
aligos therapeutics
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
baker brothers life sciences
benzodiazepine
biontech
blackstone group
blepharitis
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cavion
What
way
4
×
ipo
medicines
research
week
acquisitions
biggest
bio
biotech
biotechs
boost
build
buy
cancer
cancer’s
central
ceo
cns
companies
company’s
daniel
debut
disease
disorder
drug
drugs
dyne’s
emerged
followed
frontiers
genomics
gilead
haul
ipos
kept
known
leads
led
life
maps
Language
unset
4
×
Current search:
way
×
unset
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
